Annual accounts
Small accounts
28/02/2027Filing deadline
Made up to 31/05/2025Due 28/02/2027
- Next accounts made up to
- 31/05/2026
- Last accounts made up to
- 31/05/2025
APEX MOLECULAR LIMITED
Active- 06596885Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Block 19 Alderley Park, Mereside, Alderley Edge, Cheshire SK10 4TG
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 03/09/2026View PDF (3 pages)
Confirmation statement made on 2026-08-26 with no updates
- 18/08/2026View PDF (7 pages)
Total exemption full accounts made up to 2026-05-31
- 19/09/2025View PDF (8 pages)
Accounts for a small company made up to 2025-05-31
- 26/08/2025View PDF (7 pages)
Confirmation statement made on 2025-08-26 with updates
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 26/08/2026
- Last statement dated
- 31/05/2025
Financial performance
The latest figures APEX MOLECULAR LIMITED filed. Okredo holds filed accounts data for 2022–2026; the year-by-year record is on the financials page.
Net Assets
£601.96K2026
-43.71%vs 20252025: £1.07M
Total Assets
£777.51K2026
-40.94%vs 20252025: £1.32M
Cash in Bank
£600.09K2026
-24.33%vs 20252025: £793.01K
Total Liabilities
£175.55K2026
-28.91%vs 20252025: £246.96K
Employees
02026
0vs 20252025: 0
Of the 4 measures with an earlier filing to compare against, 4 fell. Total assets moved furthest, down 40.94% on 2025. See the full financial analysis for APEX MOLECULAR LIMITED.
The full financial record
Four ways through APEX MOLECULAR LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -39.5% a year (CAGR)Three-year trend, 2024–2026Every measure end to end across 2024, 2025 and 2026, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2022–2026.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2022–2026.
| Year | Employees | Change |
|---|---|---|
| 2026 | 0 | 0 |
| 2025 | 0 | -38 |
| 2024 | 38 | -9 |
| 2023 | 47 | +9 |
| 2022 | 38 | – |
Reported employee count decreased from 38 in 2022 to 0 in 2026. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
9Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 19/05/2008–Present | 15 | |
| Director | 01/11/2018–Present | 26 | |
| Secretary | 01/08/2009–10/05/2016 | 1 | |
| Director | 29/09/2016–Present | 3 | |
| Director | 13/06/2011–Present | 0 | |
| Director | 16/12/2016–Present | 1 | |
| Secretary | 01/01/2021–Present | 0 | |
| Secretary | 10/05/2016–29/11/2017 | 0 | |
| Secretary | 30/11/2017–01/01/2021 | 0 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 20/04/2018–Present | 0 | |
| 19/05/2017–20/04/2018 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 103 Since 19/05/2008
- Last 12 months
- 2 -2 vs the year before
- Most recent filing
- 03/09/2026 less than a month ago
What changed in the last year
- Confirmation statementLatest 03/09/2026
- Accounts filedLatest 18/08/2026
Filing timeline
- 03/09/2026View PDF (3 pages)
Confirmation statement made on 2026-08-26 with no updates
- 18/08/2026View PDF (7 pages)
Total exemption full accounts made up to 2026-05-31
- 19/09/2025View PDF (8 pages)
Accounts for a small company made up to 2025-05-31
- 26/08/2025View PDF (7 pages)
Confirmation statement made on 2025-08-26 with updates
- 24/07/2025View PDF (7 pages)
Confirmation statement made on 2025-07-10 with updates
- 07/10/2024View PDF (8 pages)
Accounts for a small company made up to 2024-05-31
- 27/02/2024View PDF (7 pages)
Confirmation statement made on 2024-02-27 with updates
- 23/01/2024View PDF (8 pages)
Accounts for a small company made up to 2023-05-31
- 06/06/2023View PDF (3 pages)
Confirmation statement made on 2023-06-06 with no updates
- 04/11/2022View PDF (4 pages)
Satisfaction of charge 065968850001 in full
- 11/10/2022View PDF (8 pages)
Accounts for a small company made up to 2022-05-31
- 30/06/2022View PDF (2 pages)
Director's details changed for Dr Peter Jackson on 2022-06-24
Showing 12 of 103 filings
See when the next accounts and confirmation statement are due
Similar companies
69 UK companies are similar to APEX MOLECULAR LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
PEPTCELL LIMITED
Active4th Floor, Silverstream House,, 45 Fitzroy Street, London W1T 6EB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 04983543
- Incorporated
- 03/12/2003
- Employees
- 0
I-BODI LTD
ActiveUnit 8 Swan Business Centre, Osier Way, Buckingham, Buckinghamshire MK18 1TB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 05572182
- Incorporated
- 23/09/2005
- Employees
- 0
LEVITY CROPSCIENCE LIMITED
ActiveCrowhall Farm Newsham Hall Lane, Woodplumpton, Preston PR4 0AS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 07125879
- Incorporated
- 14/01/2010
- Employees
- 0
LIG NANOWISE LIMITED
ActiveUnit 18, Williams House Lloyd Street North, Manchester Science Park, Manchester M15 6SE
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08835324
- Incorporated
- 07/01/2014
- Employees
- 0
LIG TECHNOLOGIES LIMITED
ActiveApartment 13 Queens College Chambers, 38 Paradise Street, Birmingham B1 2AF
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08827993
- Incorporated
- 31/12/2013
- Employees
- 0
About APEX MOLECULAR LIMITED
A short description of the company, written from its Companies House record.
APEX MOLECULAR LIMITED is a private limited company registered in the United Kingdom, based in Block 19 Alderley Park, Mereside, Alderley Edge, Cheshire SK10 4TG. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 18 years 4 months.
The register currently records it as active. Its 2026 accounts report net assets of £601.96K and 0 employees.
APEX MOLECULAR LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does APEX MOLECULAR LIMITED do?
Companies House records APEX MOLECULAR LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is APEX MOLECULAR LIMITED still active?
APEX MOLECULAR LIMITED is recorded as active on the Companies House register, and has been on it since 19/05/2008.
What are APEX MOLECULAR LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2026 and report net assets of £601.96K, total assets of £777.51K, cash in bank of £600.09K and total liabilities of £175.55K.
When did APEX MOLECULAR LIMITED last file with Companies House?
The most recent document on the record is dated 03/09/2026: Confirmation statement made on 2026-08-26 with no updates, less than a month ago.
When are APEX MOLECULAR LIMITED's next filings due?
On the current registry record, accounts are due by 28/02/2027.
Who runs APEX MOLECULAR LIMITED?
Companies House lists 9 officers (6 currently in post) and 2 people with significant control (1 current).